Showing results (51-60 of 245) with videos related to

Sort By:
Pageof 25
Hepatology (Baltimore, Md.)|March 28, 2013
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenibElisa Herraez, Elisa Lozano, Rocio I R Macias, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 18, 2015
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)Elisa Lozano, Maria J Monte, Oscar Briz, et al.
Nature Reviews. Gastroenterology & Hepatology|November 20, 2018
Wnt-β-catenin signalling in liver development, health and diseaseMaria J Perugorria, Paula Olaizola, Ibone Labiano, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2025
Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysisErman Akkus, Antonella Cammarota, Laura Izquierdo-Sanchez, et al.
Molecular Pharmaceutics|May 13, 2021
The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 VaccineElisabetta Vulpis, Francesca Giulimondi, Luca Digiacomo, et al.
Cell Death and Differentiation|April 17, 2019
RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injurySantosh Krishna-Subramanian, Stephan Singer, Marietta Armaka, et al.
Biochemical Pharmacology|March 13, 2025
Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamicsAdrian Cordido, Laura Nuñez-González, Olaya Lamas-González, et al.
European Journal of Immunology|May 22, 2014
c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cellsRosa Molfetta, Linda Quatrini, Cristina Capuano, et al.
Nanoscale|July 14, 2022
<i>In vitro</i> and <i>ex vivo</i> nano-enabled immunomodulation by the protein coronaFrancesca Giulimondi, Luca Digiacomo, Elisabetta Vulpis, et al.
Molecular Cancer Research : MCR|November 21, 2013
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma developmentElisa Lozano, Laura Sanchez-Vicente, Maria J Monte, et al.
Pageof 25